CD52 is a molecular target in advanced systemic mastocytosis.
about
Chronic mast cell leukemia: a novel leukemia-variant with distinct morphological and clinical featuresTyrosine Kinase Inhibitors and Therapeutic Antibodies in Advanced Eosinophilic Disorders and Systemic Mastocytosis.Identification of the Ki-1 antigen (CD30) as a novel therapeutic target in systemic mastocytosis.Chronic mast cell leukemia (MCL) with KIT S476I: a rare entity defined by leukemic expansion of mature mast cells and absence of organ damage.Current treatment options in patients with mastocytosis: status in 2015 and future perspectives.Establishment a CHO Cell Line Expressing Human CD52 Molecule.Mastocytosis: 2016 updated WHO classification and novel emerging treatment concepts.Targeted Treatment Options in Mastocytosis.Midostaurin: a magic bullet that blocks mast cell expansion and activation.Drug-induced inhibition of phosphorylation of STAT5 overrides drug resistance in neoplastic mast cells.The KIT and PDGFRA switch-control inhibitor DCC-2618 blocks growth and survival of multiple neoplastic cell types in advanced mastocytosis.
P2860
Q27026581-6676918D-883D-47E0-8F70-3E516760A199Q34495630-111BD77B-4F5D-42ED-907B-9E22A0A93021Q36406996-62486693-23EE-4109-B8A3-F34BFE0E6052Q36977300-DB1CD960-0F5A-46A6-8E0E-2B15F7D4A7FFQ38370943-EDC005C6-44D4-4C2C-B844-217C85035F08Q38722163-E252788A-D3B9-4B0C-9292-F3B5542CC0C3Q38777126-26E09BFE-0190-4CA2-B117-37ABAF34795FQ41061871-E7F38605-8564-4271-9E71-4CD0C0392A06Q47930594-EA048676-B238-4C7C-ADE0-8FE4C9F8AF6CQ48104415-ED19BB5B-F47C-47BC-BDAD-3138C8CBA2FDQ50035104-7655D421-0764-4F5D-859A-2AFDED7A240C
P2860
CD52 is a molecular target in advanced systemic mastocytosis.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
CD52 is a molecular target in advanced systemic mastocytosis.
@en
CD52 is a molecular target in advanced systemic mastocytosis.
@nl
type
label
CD52 is a molecular target in advanced systemic mastocytosis.
@en
CD52 is a molecular target in advanced systemic mastocytosis.
@nl
prefLabel
CD52 is a molecular target in advanced systemic mastocytosis.
@en
CD52 is a molecular target in advanced systemic mastocytosis.
@nl
P2093
P50
P356
P1433
P1476
CD52 is a molecular target in advanced systemic mastocytosis
@en
P2093
Andreas Reiter
Angelika Berger
Christoph Walz
Karl Sotlar
Karoline V Gleixner
Katharina Blatt
Leonhard Müllauer
Matthias Mayerhofer
Sabine Cerny-Reiterer
Veronika Sexl
P304
P356
10.1096/FJ.14-250894
P407
P50
P577
2014-04-23T00:00:00Z